Cargando…
Investigating Programmed Cell Death and Tumor Invasion in a Three-Dimensional (3D) Microfluidic Model of Glioblastoma
Glioblastoma multiforme (GBM) is a rapidly progressive and deadly form of brain tumor with a median survival rate of ~15 months. GBMs are hard to treat and significantly affect the patient’s physical and cognitive abilities and quality of life. Temozolomide (TMZ)—an alkylating agent that causes DNA...
Autores principales: | Samiei, Ehsan, Seyfoori, Amir, Toyota, Brian, Ghavami, Saeid, Akbari, Mohsen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246580/ https://www.ncbi.nlm.nih.gov/pubmed/32365781 http://dx.doi.org/10.3390/ijms21093162 |
Ejemplares similares
-
3D-Printed Tumor-on-a-Chip Model for Investigating the Effect of Matrix Stiffness on Glioblastoma Tumor Invasion
por: Amereh, Meitham, et al.
Publicado: (2023) -
Autophagy modulates temozolomide-induced cell death in alveolar Rhabdomyosarcoma cells
por: Moghadam, Adel Rezaei, et al.
Publicado: (2018) -
Immunology Meets Bioengineering: Improving the Effectiveness of Glioblastoma Immunotherapy
por: Fekrirad, Zahra, et al.
Publicado: (2022) -
A bioengineering method for modeling alveolar Rhabdomyosarcoma and assessing chemotherapy responses
por: Stefanek, Evan, et al.
Publicado: (2021) -
A Drug-Eluting Injectable NanoGel for Localized Delivery of Anticancer Drugs to Solid Tumors
por: Godau, Brent, et al.
Publicado: (2023)